About VasDeBlock
VasDeBlock is a Healthcare company based in Karise (Denmark) founded in 2016 by Niels Boggild Lindeburg. It operates as a non-surgical reversible male contraception is developed by VasDeBlock. It operates on a HealthTech model. VasDeBlock has raised $86.39 thousand across 3 funding rounds. VasDeBlock was last valued at $683.32 thousand in July 2021. VasDeBlock offers products and services including VasDeBlock. Its focus areas include Medical Devices and Contraceptive Devices. Its legal entity is VasDeBlock medical ApS. Its competitors include Contraline, Plan A, Bimek SLV and Ronikja; 2 of its 4 listed competitors have raised funding.
Company details
A non-surgical, hormone-free male contraception device is being developed by VasDeBlock medical ApS. The solution, marketed as a medical device, targets the healthcare sector by offering a reversible alternative to traditional sterilization methods like vasectomy and tubal ligation. It is aimed at couples seeking modern contraception options. The product is currently in the prototype and in-vivo testing phase, with patents granted in multiple regions including the US, Canada, Europe, Japan, and Australia.
- Headquarters Karise, Denmark
- Founders Niels Boggild Lindeburg
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website vasdeblock.com
- Social LinkedIn Facebook YouTube
- Legal Name Vasdeblock Medical Aps
- Total Equity Funding$86.39K (USD)
in 3 rounds
- Latest Funding Round$33.4K (USD), Seed
Jul 2021
Products & Services of VasDeBlock
VasDeBlock offers a comprehensive portfolio of products and services, including VasDeBlock.
A reversible male contraception device is being developed.
Apps and channels of VasDeBlock
its YouTube channel VasDeBlock medical ApS has 6 subscribers and 2 videos.
Videos from VasDeBlock
The most watched videos on VasDeBlock's YouTube channel, VasDeBlock medical ApS (6 subscribers). Click a video to play it here.
More on VasDeBlock medical ApS.
Funding Insights of VasDeBlock
VasDeBlock has successfully raised a total of $86.39K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $33.4 thousand completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $86,389
- Total Rounds 3
- Last Round Seed — $33,395
- First Round $28,570
(Feb 2017)
All 3 funding rounds of VasDeBlock with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2021 | $33,395 | Seed | $683,324 | – | – |
| Jan 2021 | $24,424 | Seed | $2.09M | – | – |
| Feb 2017 | $28,570 | Seed | – | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Jan 2021 | $2.09M | •••••••• |
Last known valuation $683,324 (Jul 2021).
People of VasDeBlock
1 people are tracked at VasDeBlock (1 in leadership).
| Name | Role | Group |
|---|---|---|
Niels Boggild Lindeburg | Founder | Leadership |
Complete people profiles for VasDeBlock
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of VasDeBlock
4 dated milestones of VasDeBlock across 5 years, from founding to its latest funding, stage changes and deals.
- Founded VasDeBlock is founded.
- Funding First funding round of $29K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $33K.
Competitors of VasDeBlock
VasDeBlock has 4 listed competitors in our database, 2 of them funded. They include Contraline, Plan A, Bimek SLV and Ronikja, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| contraline.com | 2015 | Charlottesville, United States | $18.62M | 7 | Contraline is focused on developing innovative male contraception solutions. | |
| planaformen.com | 2023 | San Luis Obispo, United States | $2.5M | – | Non-hormonal reversible male contraception is provided using hydrogel technology. | |
| bimek.com | 1998 | Stuttgart, Germany | – | 3 | Develops a spermatic duct valve for male contraception. | |
| ronikja.com | 2020 | Reiskirchen, Germany | – | – | Develops heat-based male contraception device and seeks crowdfunding support. |
Detailed competitors of VasDeBlock
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genitourinary Disorders
10 companies that operate in the same segment as VasDeBlock (Genitourinary Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | – | – | |
Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction | 2012 | Malvern, Pennsylvania, United States | USD 104.6 M | USD 80.28 M | 209 | |
Therapeutics for infectious and autoimmune diseases are developed. | 2010 | Cambridge, Massachusetts, United States | USD 470.49 M | – | 71 | |
Miniaturized injectable neuromodulation devices are developed for chronic diseases. | 2014 | Santa Clara, California, United States | USD 123.59 M | – | – | |
Developer of a therapeutic solution to treat prostate, kidney, and bladder cancer | 2018 | Maple Grove, Minnesota, United States | USD 157 M | – | 29 | |
A device is developed to treat urinary obstruction from BPH. | 2014 | Palo Alto, California, United States | USD 48 M | – | 25 | |
Minimally invasive devices in urology | 2004 | Mountain View, California, United States | USD 137.96 M | – | 119 | |
Diagnostic devices for lower urinary tract diseases are developed. | 2021 | Aliso Viejo, California, United States | USD 94.99 M | – | 23 | |
Medical device for benign prostatic hyperplasia treatment is developed. | 2021 | Milwaukee, Wisconsin, United States | USD 54.16 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about VasDeBlock
VasDeBlock was founded in 2016 and raised its 1st funding round 1 year after it was founded.
VasDeBlock is headquartered in Karise, Denmark.
VasDeBlock is a funded company, having raised a total of $86.39K across 3 funding rounds to date. The company's 1st funding round was a Seed of $28.57K, raised on Feb 2017.
A non-surgical, hormone-free male contraception device is being developed by VasDeBlock medical ApS. The solution, marketed as a medical device, targets the healthcare sector by offering a reversible alternative to traditional sterilization methods like vasectomy and tubal ligation. It is aimed at couples seeking modern contraception options. The product is currently in the prototype and in-vivo testing phase, with patents granted in multiple regions including the US, Canada, Europe, Japan, and Australia.
VasDeBlock's top competitors include Contraline, Plan A and Bimek SLV.
VasDeBlock offers VasDeBlock.
The valuation of VasDeBlock is $683.32K as of Jul 2021.
VasDeBlock operates through Vasdeblock Medical Aps.